PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Market Access Vaccines, MSD, Lyon, France.\', \'Center for Observational and Real-world Evidence, MSD, Madrid, Spain.\', \'Syneos Health Consulting, Value Access & HEOR, London, UK.\', \'Public Policy, MSD, Brussels, Belgium.\', \'Department of Infectious Diseases, CHU Saint-Pierre, Brussels, Belgium; Institute for Medical Immunology, Université Libre De Bruxelles (ULB), Belgium; Environmental Health Research Centre, Public Health School, Université Libre De Bruxelles (ULB), Brussels, Belgium.\', \'Pediatric Infectious Diseases Department, University of Zagreb School of Medicine, Zagreb, Croatia.\', \'Department of Health Sciences, University of Florence, Florence, Italy.\', \'Global Vaccines Medical & Scientific Affairs, MSD, Lyon, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/14760584.2021.1905257
?:doi
?:hasPublicationType
?:journal
  • Expert review of vaccines
is ?:pmid of
?:pmid
?:pmid
  • 33759675
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.551
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Immunization funding across 28 European countries.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33759675>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33759675>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all